Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Thyroid Clinical Trials

100 recruiting trials for Thyroid. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
7
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT07124000

DESTINY-PANTUMOUR04

This study will evaluate the effectiveness of T-DXd in patients with HER2-positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have received prior...

Sponsor: AstraZenecaEnrolling: 10017 locations
RECRUITINGNCT06623500

Iodine Nutrition Status and Clinical Characteristics of Thyroid Cancer

The effect of iodine nutritional status on thyroid cancer has been controversial for many years. We designed a prospective cohort study that recruiting patients in different...

Sponsor: Shandong Provincial HospitalEnrolling: 16001 location
RECRUITINGNCT07328243

Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A...

This is a single-arm, open-label, multicenter, exploratory clinical trial designed to systematically evaluate the efficacy, safety, and patient benefit of ultrasound-guided...

Sponsor: Tian'an JiangEnrolling: 851 location
RECRUITINGPhase 1NCT06569758

A Study of GenSci098 in Subjects With Active Thyroid Eye Disease

To evaluate the safety and tolerability of single and multiple ascending subcutaneous doses of GenSci098 in patients with thyroid eye disease (TED)

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Enrolling: 761 location
RECRUITINGNCT07257250

Levothyroxine Treatment and IVF Outcomes in Women With Subclinical Hypothyroidism: A Target Trial Emulation

Subclinical hypothyroidism (SCH) is defined by elevated thyroid-stimulating hormone (TSH) with normal free thyroxine (fT4) levels. It affects approximately 5-7% of women of...

Sponsor: Mỹ Đức HospitalEnrolling: 9002 locations
RECRUITINGNCT07299474

Efficacy of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures

The purpose of this study is to evaluate the efficacy of lavender aromatherapy in adult patients undergoing awake otolaryngologic procedures in the outpatient clinic setting. The...

Sponsor: Cedars-Sinai Medical CenterEnrolling: 1841 location
RECRUITINGNCT01793168

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international...

Sponsor: Sanford HealthEnrolling: 200002 locations
RECRUITINGPhase 1 / Phase 2NCT07433283

Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor

Independently developed by Sichuan Yingrui Pharmaceutical Technology Co., Ltd., CNSI-Fe is an innovative anti-cancer drug with Fe2+ as the active ingredient, which exerts...

Sponsor: Sichuan Enray Pharmaceutical Sciences CompanyEnrolling: 549 locations
RECRUITINGNCT06443866

I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer

The objective of this study is to demonstrate the clinical utility of I-124 PET/CT imaging and dosimetry in patients with thyroid cancer including 1) Evaluation of extent (volume...

Sponsor: Miami Cancer Research Center, Inc.Enrolling: 501 location
RECRUITINGNCT05391945

Effects of Thyroidectomy on Obstructive Sleep Apnea in Patients Suffering From Goiters

Literature regarding effects of goiter on the occurrence of obstructive sleep apnea (OSA) remains scarce. Reports have described cases of OSA in patients suffering from goiters,...

Sponsor: Centre Hospitalier Universitaire Saint PierreEnrolling: 1001 location
RECRUITINGPhase 3NCT06860971

A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid...

This study aims to demonstrate that, in subjects with locally advanced or metastatic iodine - refractory differentiated thyroid cancer who have failed previous VEGFR - targeted...

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Enrolling: 14420 locations
RECRUITINGNCT05172921

Environmental Factors and Thyroid Cancer

Thyroid cancer incidence has been steadily increasing and has nearly tripled since the 1970's in the US and worldwide. Early detection of small, papillary thyroid cancers using...

Sponsor: Icahn School of Medicine at Mount SinaiEnrolling: 5001 location
RECRUITINGNCT07436455

F-18 Tetrafluoroborate PET/CT in Differentiated Thyroid Cancer

In patients who have undergone surgery for differentiated thyroid cancer and who demonstrate elevated serum Tg and/or ATg levels during follow-up after radioactive iodine therapy,...

Sponsor: Ankara UniversityEnrolling: 502 locations
RECRUITINGPhase 2NCT06087068

Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma

Papillary thyroid carcinoma (PTC) is the most common thyroid cancer and has a good prognosis.According to the 2015 American thyroid association (ATA) guidelines, no gross...

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical SciencesEnrolling: 1401 location
RECRUITINGNCT06984991

Factors Influencing Inadequacy in Rapid Onsite Evaluation of Ultrasound Guided Fine Needle Aspiration (FNA) Samples of...

Thyroid nodules are a common clinical finding with a prevalence of around 50-67% in the general population using ultrasound examinations. Of these, malignancies account for 5-15%...

Sponsor: Assiut UniversityEnrolling: 1601 location
RECRUITINGPhase 3NCT06989918

MHB018A Treatment in Patients With Active Thyroid Eye Disease

The primary objective of this study is to investigate the efficacy, safety, and tolerability of MHB018A, a humanized anti-IGF1R antibody, administered q4W for 6 months, in...

Sponsor: Minghui Pharmaceutical (Hangzhou) LtdEnrolling: 1081 location
RECRUITINGNCT06695325

Convenient Home Access for Routine Monitoring in Diabetes (Charm-D Study)

Diabetes mellitus is a global problem and regular monitoring of blood sugar control is important to reduce the risk of complications secondary to poor sugar control. To assess...

Sponsor: Tameside General HospitalEnrolling: 3001 location
RECRUITINGPhase 3NCT07383246

CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC

This is a multicenter, randomized, open-label, non-inferiority Phase III clinical trial, aims to compare 68Ga-CTR-FAPI PET-CT-guided surgery to investigator-chosen surgical...

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical SciencesEnrolling: 1501 location
RECRUITINGNCT07419932

Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer

This multicenter observational study aims to evaluate the safety and efficacy of neoadjuvant therapy in patients with locally advanced thyroid cancer, focusing on imaging,...

Sponsor: Fujian Medical UniversityEnrolling: 1201 location
RECRUITINGNCT06225765

A Prospective Trial Comparing Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) and Conventional Open...

To determine if transoral endoscopic thyroidectomy vestibular approach (TOETVA) is a safe and effective procedure compared to traditional open thyroidectomy. Surgical outcomes,...

Sponsor: Tseung Kwan O Hospital, Hong KongEnrolling: 401 location
RECRUITINGNCT06358612

Evaluation of an Anxiety Reduction Tool During Thyroid Biopsies

Patients undergoing thyroid biopsy under local anesthetic will be asked to fill out a questionnaire that evaluates their anxiety level before and after their procedure. Patients...

Sponsor: Nova Scotia Health AuthorityEnrolling: 3001 location
RECRUITINGNCT01109420

Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer

Background: \- Researchers are studying types of thyroid cancer that seem to cluster in families. Non-medullary thyroid cancer accounts for the vast majority of all types of...

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling: 5001 location
RECRUITINGNCT06840106

Nasal Steam Therapy for Post-extubation Respiratory Events

The effect of symptom improvement of nasal steam strategy compared to routine management strategy for upper respiratory symptoms occurring after endotracheal intubation in...

Sponsor: Ilsan Cha hospitalEnrolling: 661 location
RECRUITINGPhase 2NCT05668962

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

This research is being done to determine the efficacy of selpercatinib to restore radioactive iodine (I-131 NaI) uptake and allow for I-131 treatment in people with RET...

Sponsor: Massachusetts General HospitalEnrolling: 306 locations
RECRUITINGNCT06220656

TRAIL Study: Feasibility and Pilot

This is a pilot study to compare two ways of managing newly identified thyroid nodules that are likely to be cancerous based on ultrasound result and which under usual care would...

Sponsor: Dartmouth-Hitchcock Medical CenterEnrolling: 201 location
RECRUITINGNCT06455371

Patient-centered Dosage of Levothyroxine

Levothyroxine is the most used thyroid hormone replacement when the thyroid gland is failing. Because dosage adjustment normally takes several months, the investigators have...

Sponsor: University Hospital of North NorwayEnrolling: 2403 locations
RECRUITINGNCT06629272

Optimizing Care for Older Adults Through Thyroid Hormone Deprescribing

The proposed study focuses on testing a novel adapted evidence-based multilevel intervention, Deprescribing Thyroid Hormone In Older Adults (D-THIO), to support thyroid hormone...

Sponsor: University of MichiganEnrolling: 9003 locations
RECRUITINGNCT06405217

Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment

Subjects: patients with postoperative local recurrent or metastatic differentiated thyroid cancer . Experimental group: Recombinant human thyroid stimulating hormone injection:...

Sponsor: Nanjing First Hospital, Nanjing Medical UniversityEnrolling: 301 location
RECRUITINGNCT06853925

Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life...

The goal of this clinical trial is to learn if adult patients diagnosed with differentiated thyroid cancer can easily use and benefit from an online tool aimed to provide patients...

Sponsor: Georgetown UniversityEnrolling: 881 location
RECRUITINGPhase 2 / Phase 3NCT06851663

Trop2-targeted immunoPET Imaging of Solid Tumors

This study aims to establish and optimize the trophoblast cell surface antigen 2 (Trop2)-targeted immuno-positron emission tomography/computed tomography (immunoPET/CT) imaging...

Sponsor: RenJi HospitalEnrolling: 4001 location
RECRUITINGPhase 1 / Phase 2NCT06814496

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Phase I study to examine safety of the addition of concurrent tarlatamab with standard palliative and consolidative RT regimens , with a main cohort of N=20-24 patients with...

Sponsor: University of ArizonaEnrolling: 302 locations
RECRUITINGNCT06133374

Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples

The purpose of this study is to determine whether results from a fine needle biopsy are the same as results from a larger sample that is acquired from the surgical pathology using...

Sponsor: University of CalgaryEnrolling: 1301 location
RECRUITINGPhase 1NCT06771219

SLV-154 Treatment of Metastatic Solid Tumors

This is a Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, pharmacodynamics, immunogenicity, and efficacy of SLV-154 across a range of dose levels when...

Sponsor: Solve TherapeuticsEnrolling: 709 locations
RECRUITINGPhase 2 / Phase 3NCT06068179

Graves' Disease Remission Study: MycoMeth Combo

A randomized study to evaluate the efficacy and safety of combining mycophenolate mofetil with methimazole in patients with newly diagnosed Graves' disease.

Sponsor: The First Affiliated Hospital of Xiamen UniversityEnrolling: 2051 location
RECRUITINGNCT05713123

Comparison of Record in VERITON Camera to the Anger Camera Procedure in Patients Treated by 131-iodine

The aim of this study is to show that the SPECT/CT whole body recording procedure lasting less than or equal to 30 minutes in a VERITON-CT™ camera, can be substituted for the...

Sponsor: Central Hospital, Nancy, FranceEnrolling: 771 location
RECRUITINGNCT05837260

Investigating Utility of ctDNA and Tumour Evolution in Advanced Thyroid Cancer

Although most thyroid cancers are treated and cured successfully there are still 30% who recur after many years. This will eventually progress and at this point may become...

Sponsor: Royal Marsden NHS Foundation TrustEnrolling: 1201 location
RECRUITINGNCT03765333

GETNE Registration of Thyroid Cancer

An epidemiological, observational, multicenter, cross-sectional, retrospective study on patients ≥ 18 years visited in the oncology services of the participating centers with...

Sponsor: Grupo Espanol de Tumores NeuroendocrinosEnrolling: 201 location
RECRUITINGPhase 1NCT06902376

XL092 and Cemiplimab in BRAF WT Thyroid Cancer

This multicenter study examines the safety and feasibility of the combination of neoadjuvant XL092 and cemiplimab prior to surgical resection in participants with wild-type (WT)...

Sponsor: UNC Lineberger Comprehensive Cancer CenterEnrolling: 122 locations
RECRUITINGPhase 1NCT07118176

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

This phase I trial is evaluating a new imaging tracer (68Ga-FAPi-46) with positron emission tomography (PET)/computed tomography (CT) to determine where and to which degree the...

Sponsor: Jonsson Comprehensive Cancer CenterEnrolling: 301 location
RECRUITINGNCT06757712

Periodization Resistance Training on Quality of Life in Females With Hypothyroidism

This study will be conducted to compare between the effect of nonlinear and linear periodized training on quality of life in females with hypothyroidism.

Sponsor: Cairo UniversityEnrolling: 751 location
RECRUITINGPhase 2NCT05989425

Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer

Locally advanced thyroid cancer has a wide range of surgery, large trauma and high local recurrence rate. It is one of the main causes of death in patients with thyroid cancer....

Sponsor: Fudan UniversityEnrolling: 321 location
RECRUITINGPhase 1NCT03647358

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

The purpose of this study is to evaluate a new diagnostic imaging test, positron emission tomography (PET), with a different radioactive form of iodine called iodine-124. This...

Sponsor: Memorial Sloan Kettering Cancer CenterEnrolling: 601 location
RECRUITINGPhase 2NCT03841617

The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer

Study rationale High risk patients with differentiated thyroid cancer (DTC) require therapy with 131 I under thyroid stimulating hormone (TSH) stimulation. There are two methods...

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling: 301 location
RECRUITINGNCT06963203

Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis

The goal of this observational study is to learn about the potential differences in morbidity of thyroidectomy (removal of the thyroid gland) depending on the preoperative...

Sponsor: Andrea GoldmannEnrolling: 48615 locations
RECRUITINGPhase 2NCT06440850

Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With...

This phase II trial tests how well vemurafenib and cobimetinib work in treating patients with high risk differentiated thyroid carcinoma with BRAFV600E mutation, in preparation...

Sponsor: City of Hope Medical CenterEnrolling: 211 location
RECRUITINGPhase 1 / Phase 2NCT05451602

HEC169096 in Participants With Advanced Solid Tumors

An Open, Multi-Center Phase I/II Clinical Study To Evaluate The Safety, Tolerability, Pharmacokinetic Characteristics And Effectiveness Of HEC169096 In Patients With Thyroid...

Sponsor: Sunshine Lake Pharma Co., Ltd.Enrolling: 4561 location
RECRUITINGNCT06275373

The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction

This protocol studies the clinical outcome of patients with active thyroid disease with visually significant signs and symptoms of proptosis, pain, diplopiam lid/orbital edema, or...

Sponsor: Walter Reed National Military Medical CenterEnrolling: 1001 location
RECRUITINGNCT04615988

Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors

The purpose of this research study is to see if the amount of vitamin D in ones blood makes it more or less likely to develop thyroid gland toxicity when being treated with...

Sponsor: Icahn School of Medicine at Mount SinaiEnrolling: 171 location
RECRUITINGNCT07360587

Thyroid Artery Embolization for the Treatment of Compressive Goiters.

Very few studies have investigated TAE as a treatment for goiter with compressive symptoms. What is the efficacy and safety of TAE for the treatment of compressive goiters in a...

Sponsor: Université de SherbrookeEnrolling: 201 location
RECRUITINGNCT06855680

The EMIRATES Study

This pilot study will take place in thyroid outpatient clinics. It will have two study arms running in consecutive order: first, a Control arm where standard care will take place...

Sponsor: Royal Marsden NHS Foundation TrustEnrolling: 151 location

Showing 50 of 100 trials.Search all Thyroid trials

Frequently Asked Questions

There are currently 100 clinical trials for Thyroid, with 100 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Thyroid, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 7 Phase 3 trials for Thyroid, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.

For this entity, the underlying data on this page comes from the NIH ClinicalTrials.gov registry. The breakdown above is the federal record; the paragraphs below add the per-entity context that makes the headline numbers usable for a real decision rather than just a data lookup.

Every number on this page links back to the NIH ClinicalTrials.gov registry; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.

For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for this entity is typically a peer within active and historical clinical trials with similar size, similar exposure, or similar geography — not the national-level summary alone.